BioNexus Gene Lab Corp. (NASDAQ:BGLC – Get Free Report) was the target of a large increase in short interest during the month of December. As of December 15th, there was short interest totalling 197,100 shares, an increase of 164.6% from the November 30th total of 74,500 shares. Based on an average daily trading volume, of 602,900 shares, the short-interest ratio is currently 0.3 days. Currently, 1.7% of the shares of the company are sold short.
BioNexus Gene Lab Price Performance
BioNexus Gene Lab stock opened at $0.24 on Friday. BioNexus Gene Lab has a twelve month low of $0.21 and a twelve month high of $3.39. The company’s 50-day moving average price is $0.31 and its two-hundred day moving average price is $0.40.
About BioNexus Gene Lab
Featured Stories
- Five stocks we like better than BioNexus Gene Lab
- What is the Dogs of the Dow Strategy? Overview and Examples
- Top 3 Investment Themes to Watch for in 2025
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- Short Selling: How to Short a Stock
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for BioNexus Gene Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNexus Gene Lab and related companies with MarketBeat.com's FREE daily email newsletter.